The Costs and Valuation of Health Impacts of Measles and Rubella Risk Management Policies
by Kimberly M. Thompson and Cassie L. Odahowski, Risk Analysis 2016; 36(7):1357-1382 (published on-line August 5, 2015, doi: 10.1111/risa.12459)

Answers to frequently asked questions

What are the study’s main findings?
What are the study’s main recommendations?
Background on measles and rubella

What are the study’s main findings?

What are the study’s main recommendations?

Correction to Table IX

      GBD 2010     GBD 1990  
Measles DALY by age (yr) Low LMI UMI High Low LMI UMI High
0 per infection 1.16 1.16 1.09 0.11 1.18 1.18 1.11 0.11
4 per infection 1.09 1.09 1.03 0.11 1.11 1.11 1.05 0.11
5 per infection 0.72 0.72 0.68 0.03 0.72 0.72 0.68 0.04
14 per infection 0.61 0.62 0.59 0.03 0.61 0.62 0.59 0.03
15 per infection 0.93 0.94 0.92 0.10 0.93 0.94 0.92 0.10
44 per infection 0.36 0.41 0.47 0.06 0.36 0.41 0.47 0.06
45 per infection 0.34 0.39 0.46 0.06 0.34 0.39 0.46 0.06
60 per infection 0.04 0.12 0.22 0.04 0.04 0.12 0.22 0.04